Skip to content

How It Works Pricing Blog Events Partners

Sign In Get Started →

How It Works Pricing Blog Events Partners

Sign In Get Started →

Loading people...

The OS for early-stage founders from day zero to raise.

Product

How It Works Pricing Partners

Resources

Blog Events Contact

Company

About Privacy Terms

© 2026 Startup Intros, Inc.San Francisco, CA · Made for Founders

Home
/People
/Alex DePaoli

§ Investor Profile

Alex DePaoli

Updated:Apr 2, 2026

About News Experience Investments FAQs

Quick Facts

Role: Chief Medical Officer and Vice President Translational Research
Company: NGM Biopharmaceuticals
Status: Active
Type: Investor

Subscribe, Save or Share

Join 25K+ founders & VCs who start their week informed.

Recent News & Mentions

Jul 1, 2024FundingNGM Biopharmaceuticals - Series A Mar 1, 2015FundingNGM Biopharmaceuticals - Series D Jul 18, 2013FundingNGM Biopharmaceuticals - Series C Mar 1, 2010FundingNGM Biopharmaceuticals - Series B Dec 1, 2009FundingNGM Biopharmaceuticals - Series A Feb 12, 2008FundingNGM Biopharmaceuticals - Other Equity

Experience

Chief Medical Officer and Vice President Translational ResearchCurrent

NGM Biopharmaceuticals

Present - Present

Frequently Asked Questions

Who is Alex DePaoli?

Alex DePaoli is Chief Medical Officer and Vice President Translational Research at NGM Biopharmaceuticals.